|
Volumn 46, Issue 2, 2006, Pages 222-228
|
Effect of R667, a novel emphysema agent, on the pharmacokinetics of midazolam in healthy men
a,c b a a b a |
Author keywords
CYP3A4; Emphysema; Midazolam
|
Indexed keywords
1 HYDROXYMIDAZOLAM;
CYTOCHROME P450 3A4;
DRUG METABOLITE;
MIDAZOLAM;
MIDAZOLAM MALEATE;
NEW DRUG;
R 667;
UNCLASSIFIED DRUG;
ADULT;
AREA UNDER THE CURVE;
ARTHRALGIA;
ARTICLE;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DIARRHEA;
DIZZINESS;
DREAMING;
DRUG BLOOD LEVEL;
DRUG EFFECT;
DRUG HALF LIFE;
DRUG METABOLISM;
DRUG SAFETY;
DRUG STRUCTURE;
EMPHYSEMA;
HEADACHE;
HUMAN;
INJECTION SITE CONTUSION;
ISCHIALGIA;
LYMPHOCYTOPENIA;
MALE;
NORMAL HUMAN;
OPEN STUDY;
RASH;
SIDE EFFECT;
SINGLE DRUG DOSE;
ADULT;
AREA UNDER CURVE;
BIOTRANSFORMATION;
CROSS-OVER STUDIES;
CYTOCHROME P-450 ENZYME SYSTEM;
EMPHYSEMA;
HALF-LIFE;
HUMANS;
HYPNOTICS AND SEDATIVES;
MALE;
MIDAZOLAM;
PYRAZOLES;
|
EID: 31344472168
PISSN: 00912700
EISSN: 15524604
Source Type: Journal
DOI: 10.1177/0091270005283836 Document Type: Article |
Times cited : (6)
|
References (7)
|